Kronos Bio Profit Margin

Kronos Bio (KRON) currently reports a profit margin of -701.53% as of March 2025. That compares with -1534.11% in the prior-year period — up 54.3% year over year. That is below the Healthcare sector average of 15.58%. Use the charts on this page to explore Kronos Bio's profit margin history and peer comparisons.

Kronos Bio's profit margin increased from -1534.11% to -701.53% — a 54.3% year-over-year increase (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Kronos Bio's profit margin of -701.53% is lower than the Healthcare sector average of 15.58%. That is roughly 4601.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Kronos Bio's current -701.53% should be judged against Healthcare norms (sector average: 15.58%) and against KRON's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -701.53%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.58%. From there, open related valuation or income-statement pages for Kronos Bio, and consider following KRON for alerts when major investors trade the stock.